
Limited Clinical Benefit of Extracorporeal Shockwave Therapy for Insertional Achilles Tendinopathy
How to Cite
OrthoEvidence. Limited Clinical Benefit of Extracorporeal Shockwave Therapy for Insertional Achilles Tendinopathy . ACE Report. 2020;9(12):18. Available from: https://myorthoevidene.com/AceReport/Report/12446
Effectiveness of Extracorporeal Shockwave Therapy in the Treatment of Chronic Insertional Achilles Tendinopathy.
Foot Ankle Int . 2020 Apr;41(4):403-410Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Thirty-one patients with chronic insertional Achilles tendinopathy were randomized to receive low-energy extracorporeal shockwave therapy (ESWT) (n=16) or sham therapy (n=15). The primary outcome of interest was pain on a Visual Analogue Scale (VAS). The secondary outcome of interest was the VAS foot and ankle (VAS-FA) total score and pain, function and other complaints sub-scores. Additionally, t...
To view the full report, start your 30-day free trial today
No credit card required
JOIN LOGIN Forgot Password?Not sure if you want to join OrthoEvidence?
Access this report without an Account.Success, an email containing a link to access this report has been sent to your inbox.
Explore some of our unlocked reports below!

Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.
LEARN MORE
Please Login or Join to leave comments.